AU2001289834A1 - Diagnostic and therapeutic use of a caveolae-associated integral membrane protein for alzheimer's disease and related neurodegenerative disorders - Google Patents
Diagnostic and therapeutic use of a caveolae-associated integral membrane protein for alzheimer's disease and related neurodegenerative disordersInfo
- Publication number
- AU2001289834A1 AU2001289834A1 AU2001289834A AU8983401A AU2001289834A1 AU 2001289834 A1 AU2001289834 A1 AU 2001289834A1 AU 2001289834 A AU2001289834 A AU 2001289834A AU 8983401 A AU8983401 A AU 8983401A AU 2001289834 A1 AU2001289834 A1 AU 2001289834A1
- Authority
- AU
- Australia
- Prior art keywords
- caveolae
- alzheimer
- diagnostic
- disease
- membrane protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22729400P | 2000-08-24 | 2000-08-24 | |
| EP00118443 | 2000-08-24 | ||
| EP00118443.1 | 2000-08-24 | ||
| US60/227,294 | 2000-08-24 | ||
| PCT/EP2001/009802 WO2002016636A2 (en) | 2000-08-24 | 2001-08-24 | Diagnostic and therapeutic use of a caveolae-associated integral membrane protein for alzheimer's disease and related neurodegenerative disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001289834A1 true AU2001289834A1 (en) | 2002-03-04 |
Family
ID=31985005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001289834A Abandoned AU2001289834A1 (en) | 2000-08-24 | 2001-08-24 | Diagnostic and therapeutic use of a caveolae-associated integral membrane protein for alzheimer's disease and related neurodegenerative disorders |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20040053265A1 (en) |
| EP (1) | EP1377678A2 (en) |
| AU (1) | AU2001289834A1 (en) |
| WO (1) | WO2002016636A2 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060073480A1 (en) * | 2002-04-08 | 2006-04-06 | Heinz Von Der Kammer | Diagnostic and therapeutic use of vault polynucleotides and proteins for neurodegenerative diseases |
| US20060052280A1 (en) * | 2002-04-14 | 2006-03-09 | Heinz Von Der Kammer | Diagnostic and therapeutic use of a golgi protein for neurodegenerative diseases |
| WO2003091734A1 (en) * | 2002-04-24 | 2003-11-06 | Evotec Neurosciences Gmbh | Diagnostic and therapeutic use of ensadin-0477 gene and protein for neurodegenerative diseases |
| WO2003100092A2 (en) * | 2002-05-28 | 2003-12-04 | Evotec Neurosciences Gmbh | Diagnostic and therapeutic use of cyp11a1 for neurodegenerative diseases |
| US20070269800A9 (en) * | 2002-08-28 | 2007-11-22 | Heinz Von Der Kammer | Diagnostic and therapeutic use of foap-13 polynucleotides and polypeptides for neurodegenerative diseases |
| WO2004020666A2 (en) * | 2002-09-02 | 2004-03-11 | Evotec Neurosciences Gmbh | Diagnostic and therapeutic use of thyroid hormone binding protein for neurodegenerative diseases |
| EP1771578A2 (en) * | 2004-07-23 | 2007-04-11 | EVOTEC Neurosciences GmbH | Diagnostic and therapeutic use of slim3 for neurodegenerative diseases |
| WO2007050554A2 (en) * | 2005-10-25 | 2007-05-03 | The Trustees Of Columbia University In The City Of New York | Methods for identifying compounds that modulate phb domain protein activity and compositions thereof |
| EP3101424B1 (en) * | 2015-06-04 | 2023-01-04 | Euroimmun Medizinische Labordiagnostika AG | Diagnosis of a neuroautoimmune disease |
| JP7033840B2 (en) | 2016-06-17 | 2022-03-11 | ユーロイミューン・メディツィニシェ・ラボルディアグノシュティカ・アクチエンゲゼルシャフト | Diagnosis of neuroautoimmune diseases |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5294993A (en) * | 1992-10-01 | 1994-04-26 | Board Of Regents, The University Of Texas System | Epidermal surface antigen and uses thereof |
| US5607967A (en) * | 1994-10-27 | 1997-03-04 | Merck & Co., Inc. | Treatment of alzheimer's disease with 5-(tetradecyloxy)-2-furan carboxylic acid |
| US5955308A (en) * | 1997-06-18 | 1999-09-21 | Smithkline Beecham Corporation | cDNA clone HEAOD54 that encodes a human 7-transmembrane receptor |
| EP1165789A2 (en) * | 1999-04-07 | 2002-01-02 | Incyte Pharmaceuticals, Inc. | Vesicle associated proteins |
-
2001
- 2001-08-24 AU AU2001289834A patent/AU2001289834A1/en not_active Abandoned
- 2001-08-24 WO PCT/EP2001/009802 patent/WO2002016636A2/en not_active Application Discontinuation
- 2001-08-24 US US10/362,129 patent/US20040053265A1/en not_active Abandoned
- 2001-08-24 EP EP01969643A patent/EP1377678A2/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002016636A3 (en) | 2003-10-09 |
| EP1377678A2 (en) | 2004-01-07 |
| US20040053265A1 (en) | 2004-03-18 |
| WO2002016636A2 (en) | 2002-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001278084A1 (en) | Model for alzheimer's disease and other neurodegenerative diseases | |
| AU2001249835A1 (en) | Diagnosis and treatment of alzheimer's disease | |
| AU5508798A (en) | Diagnostic and therapeutic reagents for alzheimer's disease | |
| AU2003206413A1 (en) | Substituted amino carboxamides for the treatment of alzheimer's disease | |
| IL149924A0 (en) | Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases | |
| AU1407399A (en) | Treatment for alzheimer's disease | |
| AU2610901A (en) | Predictive diagnostic for alzheimer's disease | |
| AU2002363825A1 (en) | Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases | |
| AU2002335794A1 (en) | Allylamides useful in the treatment of alzheimer's disease | |
| AU2001289834A1 (en) | Diagnostic and therapeutic use of a caveolae-associated integral membrane protein for alzheimer's disease and related neurodegenerative disorders | |
| AU2001236592A1 (en) | Methods for diagnosis of alzheimer's disease | |
| AU2002330215A1 (en) | Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease | |
| AU2002239765A1 (en) | Antibody pti-hs7 for treatment of alzheimer's disease and other amyloidoses and parkinson's disease | |
| AU2002222108A1 (en) | Diagnosis and treatment of alzheimer's disease | |
| AU5053296A (en) | Pharmaceutical agents for the treatment of Alzheimer's disease | |
| HUP9903213A1 (en) | Use of 2-phenyl-1,2-benzisoselenazol-3(2h)-one for producing a pharmaceutical preparation intended for treatment of the alzheimer's disease and the medicament itself | |
| AU2002302238A1 (en) | A method of treatment of alzheimer's disease and device therefor | |
| AU2729400A (en) | Application of a viral complement inhibitory protein in the treatment and diagnosis of alzheimer's disease | |
| AU5550800A (en) | Diagnosis and treatment of alzheimer's disease | |
| AU1405899A (en) | Treatment for alzheimer's disease | |
| AU2002312667A1 (en) | Individualization of therapy with alzheimer's disease agents | |
| AU2002212233A1 (en) | Diagnostic and therapeutic use of a phosphoprotein enriched in astrocytes for alzheimer's disease and related neurodegenerative disorders | |
| AU2002357232A1 (en) | Peptide isosteres containing a heterocycle useful in the treatment of alzheimer's disease | |
| AU2002315290A1 (en) | Diagnostic and therapeutic use of a nuclear restricted protein for alzheimer's disease and related neurodegenerative disorders | |
| AU2002333808A1 (en) | Diagnostic and therapeutic use of f-box proteins for alzheimer's disease and related neurodegenerative disorders |